中文｜English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 39 Issue 7
Jul.  2023
Turn off MathJax
Article Contents
Article Navigation >  Journal of Clinical Hepatology  > 2023  >  39(7): 1627-1632

Analysis of influencing factors on biliary complications after orthotopic liver transplantation

DOI: 10.3969/j.issn.1001-5256.2023.07.017

  • Department of Hepatobiliary Surgery, Renmin Hospital of Wuhan University, Wuhan 430060, China

Research funding:

National Key Research and Development Program (2022YFC2407304)

More Information
  • Corresponding author: DING Youming, dingym62@163.com (ORCID: 0000-0001-6695-3275)
  • Received Date: 2022-11-24
  • Accepted Date: 2023-01-09
  • Published Date: 2023-07-20
    Abstract
  •   Objective  To analyze the serological markers and surgical indicators associated with biliary complications after orthotopic liver transplantation, explore their influencing factors and predictive indicators.  Methods  A retrospective analysis was performed for the clinical data of 101 patients who underwent orthotopic liver transplantation in Renmin Hospital of Wuhan University from January 2016 to June 2022, according to the presence or absence of biliary complication (BC) at 6 months after surgery, they were divided into BC group with 21 patients and non-BC group with 80 patients.The t-test or the Mann-Whitney U test was used for comparison of continuous data between groups, and the chi-square test was used for comparison of categorical data between groups.Univariate and multivariate Logistic regression analyses were performed, and the receiver operating characteristic (ROC) curve was used to evaluate the predictive performance of combined indicators.  Results  Among the 101 patients, 21(20.8%) experienced BC.The multivariate Logistic regression analysis showed that MELD score (odds ratio[OR]=0.134, 95% confidence interval[CI]: 0.031-0.590, P=0.008), SⅡ/Alb (OR=1.415, 95%CI: 1.181-1.696, P=0.001), and plasma transfusion volume (OR=1.001, 95%CI: 1.000-1.002, P=0.032) were independent risk factors for the development of BC in patients after liver transplantation.MELD score, SⅡ/Alb, plasma transfusion volume, MELD+SⅡ/Alb, and MELD+SⅡ/Alb+plasma transfusion volume had an area under the ROC curve of 0.712, 0.870, 0.712, 0.900, and 0.918, respectively, in predicting BC after liver transplantation.  Conclusion  SⅡ/Alb, plasma transfusion volume and MELD score are independent risk fators for BC after liver transplantation.The combination of three indicators has good predictive value and clinical guiding significance for BC after liver transplantation.

     

    • FullText(HTML)
  • loading
    • References(29)
  • [1]
    SAMUEL D, COILLY A. Management of patients with liver diseases on the waiting list for transplantation: A major impact to the success of liver transplantation[J]. BMC Med, 2018, 16(1): 113. DOI: 10.1186/s12916-018-1110-y.
    [2]
    BERTACCO A, BARBIERI S, GUASTALLA G, et al. Risk factors for mortality in liver transplant patients[J]. Transplant Proc, 2019, 51 (1): 179-183. DOI: 10.1016/j.transproceed.2018.06.025
    [3]
    AKAMATSU N, SUGAWARA Y, HASHIMOTO D. Biliary reconstruction, its complications and management of biliary complications after adult liver transplantation: A systematic review of the incidence, risk factors and outcome[J]. Transpl Int, 2011, 24(4): 379-392. DOI: 10.1111/j.1432-2277.2010.01202.x.
    [4]
    FORDE JJ, BHAMIDIMARRI KR. Management of biliary complications in liver transplant recipients[J]. Clin Liver Dis, 2022, 26(1): 81-99. DOI: 10.1016/j.cld.2021.08.008.
    [5]
    HU XW, LI T. Diagnosis and treatment of common biliary complications after orthotopic liver transplantation in adults[J]. Organ Transplant, 2022, 13(5): 569-576. DOI: 10.3969/j.issn.1674-7445.2022.05.004.

    胡鑫文, 李亭. 成人原位肝移植术后常见胆道并发症的诊疗[J]. 器官移植, 2022, 13(5): 569-576. DOI: 10.3969/j.issn.1674-7445.2022.05.004.
    [6]
    KOCHHAR G, PARUNGAO JM, HANOUNEH IA, et al. Biliary complications following liver transplantation[J]. World J Gastroenterol, 2013, 19(19): 2841-2846. DOI: 10.3748/wjg.v19.i19.2841.
    [7]
    TRAN LT, CARULLO PC, BANH DPT, et al. Pediatric liver transplantation: Then and now[J]. J Cardiothorac Vasc Anesth, 2020, 34(8): 2028-2035. DOI: 10.1053/j.jvca.2020.02.019.
    [8]
    GREIF F, BRONSTHER OL, VAN THIEL DH, et al. The incidence, timing, and management of biliary tract complications after orthotopic liver transplantation[J]. Ann Surg, 1994, 219(1): 40-45. DOI: 10.1097/00000658-199401000-00007.
    [9]
    TAI Q, HE XS, YANG JA, et al. The diagnosis and treatment of biliary complications in liver transplant patients[J]. Chin J Gen Surg, 2010, 25(12): 969-972. DOI: 10.3760/cma.j.issn.1007-631X.2010.12.010.

    邰强, 何晓顺, 杨建安, 等. 肝移植术后胆道并发症的诊断与治疗[J]. 中华普通外科杂志, 2010, 25(12): 969-972. DOI: 10.3760/cma.j.issn.1007-631X.2010.12.010.
    [10]
    FANG C, YAN S, ZHENG SS. Influencing factors, diagnosis and treatment of biliary complications after liver transplantation[J]. Chin J Gen Surg, 2014, 29(6): 486-488. DOI: 10.3760/cma.j.issn.1007-631X.2014.06.028.

    方程, 严盛, 郑树森. 肝移植术后胆道并发症的影响因素及诊治进展[J]. 中华普通外科杂志, 2014, 29(6): 486-488. DOI: 10.3760/cma.j.issn.1007-631X.2014.06.028.
    [11]
    KALTENBORN A, GUTCKE A, GWIASDA J, et al. Biliary complications following liver transplantation: Single-center experience over three decades and recent risk factors[J]. World J Hepatol, 2017, 9(3): 147-154. DOI: 10.4254/wjh.v9.i3.147.
    [12]
    SARHAN MD, OSMAN AMA, MOHAMED MA, et al. Biliary complications in recipients of living-donor liver transplant: A single-center review of 120 patients[J]. Exp Clin Transplant, 2017, 15(6): 648-657. DOI: 10.6002/ect.2016.0210.
    [13]
    WIEDERKEHR JC, IGREJA MR, NOGARA MS, et al. Analysis of survival after primary liver transplantation: Multivariate analysis of 155 cases in a single center[J]. Transplant Proc, 2010, 42(2): 511-512. DOI: 10.1016/j.transproceed.2010.01.014.
    [14]
    GIRARD E, RISSE O, ABBA J, et al. Internal biliary stenting in liver transplantation[J]. Langenbecks Arch Surg, 2018, 403(4): 487-494. DOI: 10.1007/s00423-018-1669-y.
    [15]
    YOON JU, BYEON GJ, PARK JY, et al. Bloodless living donor liver transplantation: Risk factors, outcomes, and diagnostic predictors[J]. Medicine, 2018, 97(50): e13581. DOI: 10.1097/MD.0000000000013581.
    [16]
    JACOB M, COPLEY LP, LEWSEY JD, et al. Pretransplant MELD score and post liver transplantation survival in the UK and Ireland[J]. Liver Transpl, 2004, 10(7): 903-907. DOI: 10.1002/lt.20169.
    [17]
    ODEN-BRUNSON H, MCDONALD MF, GODFREY E, et al. Is liver transplant justified at any MELD score?[J]. Transplantation, 2023, 107(3): 680-692. DOI: 10.1097/tp.0000000000004345.
    [18]
    LIU CC. Real-world study on SⅡ/ALB ratio to predict the efficacy of immune checkpoint inhibitors in the treatment of malignant tumors[D]. Dalian: Dalian Medical University, 2021.

    刘成成. SⅡ/ALB比值预测免疫检查点抑制剂治疗恶性肿瘤疗效真实世界研究[D]. 大连: 大连医科大学, 2021.
    [19]
    LI HW, WANG GC, ZHANG HH, et al. Prognostic role of the systemic immune-inflammation index in brain metastases from lung adenocarcinoma with different EGFR mutations[J]. Genes Immun, 2019, 20(6): 455-461. DOI: 10.1038/s41435-018-0050-z.
    [20]
    AN R, QIN C, WU Q, et al. Predictive value of systemic immune inflammation index (SⅡ)in the short-term prognosis of patients with dilated cardiomyopathy[J]. Clin J Med Offic, 2022, 50(11): 1129-1133. DOI: 10.16680/j.1671-3826.2022.11.07.

    安然, 秦璨, 武琼, 等. 全身免疫炎症指数对扩张型心肌病患者预后预测价值[J]. 临床军医杂志, 2022, 50(11): 1129-1133. DOI: 10.16680/j.1671-3826.2022.11.07.
    [21]
    REN A, LI ZQ, CHENG PR, et al. Systemic immune-inflammation index is a prognostic predictor in patients with intrahepatic cholangiocarcinoma undergoing liver transplantation[J]. Mediators Inflamm, 2021, 2021: 6656996. DOI: 10.1155/2021/6656996.
    [22]
    FU HY, ZHENG J, CAI JY, et al. Systemic immune-inflammation index (SⅡ) is useful to predict survival outcomes in patients after liver transplantation for hepatocellular carcinoma within Hangzhou criteria[J]. Cell Physiol Biochem, 2018, 47(1): 293-301. DOI: 10.1159/000489807.
    [23]
    LICHTENEGGER P, SCHIEFER J, GRAF A, et al. The association of pre-operative anaemia with survival after orthotopic liver transplantation[J]. Anaesthesia, 2020, 75(4): 472-478. DOI: 10.1111/anae.14918.
    [24]
    JÓŹWIK A, KARPETA E, NITA M, et al. Impact of blood loss and intraoperative blood transfusion during liver transplantation on the incidence of early biliary complications and mortality[J]. Transplant Proc, 2020, 52(8): 2477-2479. DOI: 10.1016/j.transproceed.2020.03.052.
    [25]
    CHU HH, KIM JH, SHIM JH, et al. Neutrophil-to-lymphocyte ratio as a biomarker predicting overall survival after chemoembolization for intermediate-stage hepatocellular carcinoma[J]. Cancers (Basel), 2021, 13(11): 2830. DOI: 10.3390/cancers13112830.
    [26]
    NYLEC M, DERBISZ K, CHRZ SZCZ P, et al. Preoperative neutrophil-to-lymphocyte ratio as an independent predictor of 1-year graft loss and mortality after orthotopic LiverTransplantation[J]. Transplant Proc, 2020, 52(8): 2472-2476. DOI: 10.1016/j.transproceed.2020.03.036.
    [27]
    KWON HM, MOON YJ, JUNG KW, et al. Neutrophil-to-lymphocyte ratio is a predictor of early graft dysfunction following living donor liver transplantation[J]. Liver Int, 2019, 39(8): 1545-1556. DOI: 10.1111/liv.14103.
    [28]
    LUÉ A, SOLANAS E, BAPTISTA P, et al. How important is donor age in liver transplantation?[J]. World J Gastroenterol, 2016, 22(21): 4966-4976. DOI: 10.3748/wjg.v22.i21.4966.
    [29]
    ZHANG QB, SHEN CH, TAO YF, et al. Risk factor analysis and classified therapeutic strategies for biliary complications after liver transplantation from organ donation by citizens after death: A report of 48 cases at a single center[J]. Chin J Organ Transplant, 2020, 41(10): 623-628. DOI: 10.3760/cma.j.cn421203-20191115-00415.

    张全保, 沈丛欢, 陶一峰, 等. 肝移植术后胆道并发症的危险因素分析及分类治疗策略[J]. 中华器官移植杂志, 2020, 41(10): 623-628. DOI: 10.3760/cma.j.cn421203-20191115-00415.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(1)  / Tables(3)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (238) PDF downloads(27) Cited by()
    Proportional views
    Related
        

    The first journal specializing in hepatobiliary and pancreatic diseases in China

    Supervisor：Ministry of Education of the People's Republic of China

    Sponsor：Jilin University

    Academic Support: Chinese Society of Hepatology，Chinese Medical Association

    Address: 461 Xinjiang Road, Changchun

    Submit：0431-88782044

    Peer review：0431-88783542

    Email：lcgdb@vip.163.com

    About Journal

    Submission Guideline

    Journal Online

    Hepatobiliary College

    Guidelines

    YesterdayIP[]YesterdayPV[]TodayIP[]TodayPV[]Online[]

    Website Design © 2020 Editorial Board of Journal of Clinical Hepatology 吉ICP备10000617号-1 Supported by: Beijing Renhe Information Technology Co. Ltd  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return